Subscribe
shutterstock_1595586766_ken_wolter
Ken Wolter / Shutterstock.com
1 March 2022AmericasAlex Baldwin

USPTO rules Broad owns CRISPR animal cell editing patents

Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office (USPTO) has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
US appeals court restores five CRISPR patents with precedential opinion on interferences
20 July 2023   SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.
Biotechnology
Biotech secures CRISPR patent for COVID-19 diagnostic test
21 February 2023   Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.
Genetics
Will de-extinct animals be patent eligible in the US?
5 January 2023   Science fiction is becoming science fact but the Alice/Mayo framework throws up some interesting challenges to bringing life back from the dead, explains Brian Hausman of Baker Botts.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Big Pharma
US appeals court restores five CRISPR patents with precedential opinion on interferences
20 July 2023   SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.
Biotechnology
Biotech secures CRISPR patent for COVID-19 diagnostic test
21 February 2023   Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.
Genetics
Will de-extinct animals be patent eligible in the US?
5 January 2023   Science fiction is becoming science fact but the Alice/Mayo framework throws up some interesting challenges to bringing life back from the dead, explains Brian Hausman of Baker Botts.

More on this story

Big Pharma
US appeals court restores five CRISPR patents with precedential opinion on interferences
20 July 2023   SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.
Biotechnology
Biotech secures CRISPR patent for COVID-19 diagnostic test
21 February 2023   Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.
Genetics
Will de-extinct animals be patent eligible in the US?
5 January 2023   Science fiction is becoming science fact but the Alice/Mayo framework throws up some interesting challenges to bringing life back from the dead, explains Brian Hausman of Baker Botts.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB